4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-002081
10% owner bought 300,000 shares at $21.00 ($6,300,000)
- 10% owner acquired 7,613,887 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
UBS Oncology Impact Fund L.P. · 10% owner
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-12 | Conversion : show line 1 in the form | +1,136,525 | 1,136,525 | D | ||
| 2021-01-12 | Conversion : show line 2 in the form | +3,551,640 | 4,688,165 | D | ||
| 2021-01-12 | Conversion : show line 3 in the form | +2,276,692 | 6,964,857 | D | ||
| 2021-01-12 | Conversion : show line 4 in the form | +649,030 | 7,613,887 | D | ||
| 2021-01-12 | Purchase : show line 5 in the form | +300,000 | $21.00 | $6,300,000 | 7,913,887 | D |
| Open-market purchases · 300,000 sh · avg $21.00 · $6,300,000 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-12 | Conversion : show line 6 in the form Series Seed Convertible Preferred Stock | −1,136,525 | 0 | D |
| 2021-01-12 | Conversion : show line 7 in the form Series A Convertible Preferred Stock | −3,551,640 | 0 | D |
| 2021-01-12 | Conversion : show line 8 in the form Series B Convertible Preferred Stock | −2,276,692 | 0 | D |
| 2021-01-12 | Conversion : show line 9 in the form Series C Convertible Preferred Stock | −649,030 | 0 | D |
Loading xslF345X03/doc4.xml…